Inequity of access to implantable cardioverter defibrillator therapy in England: Possible causes of geographical variation in implantation rates

Europace

Volumn 11, Issue 10, 2009, Pages 1308-1312

  McComb, Janet M ^a   Plummer, Christopher J ^a   Cunningham, Morag W ^b   Cunningham, David ^b  

^a FREEMAN HOSPITAL   (United Kingdom)

^b Central Cardiac Audit Database   (United Kingdom)

Author keywords

Geographical variation; Implantable cardioverter defibrillator; Inequity

Indexed keywords

AMIODARONE;

ANGIOPLASTY; ARTICLE; ARTIFICIAL HEART PACEMAKER; CORONARY ARTERY BYPASS SURGERY; DEFIBRILLATOR; GEOGRAPHIC DISTRIBUTION; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART VENTRICLE TACHYCARDIA; HUMAN; IMPLANT REGISTRY; ISCHEMIC HEART DISEASE; PRIORITY JOURNAL; REVASCULARIZATION; SOCIOECONOMICS; SUDDEN DEATH; UNITED KINGDOM;

AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; ARRHYTHMIAS, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; EMPLOYMENT; ENGLAND; FEMALE; HEALTH SERVICES ACCESSIBILITY; HEALTHCARE DISPARITIES; HUMANS; MALE; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; PREVALENCE; SEX DISTRIBUTION; SOCIAL CLASS; TOPOGRAPHY, MEDICAL;

EID: 70349505859     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eup264     Document Type: Article

References (40)

1. Mond HG, Irwin M, Morillo C, Ector H. The world survey of cardiac pacing and cardioverter defibrillators: calendar year 2001. PACE 2004;27:955-964
2. Ector H, Linde C, Vardas P, Le Heuzy J-Y, Brugada J, Blomstrom-Lundqvist C et al. Cardiac pacing in Europe: indications and demographic data: years 2000-2001-2002. Europace 2005;7 (Suppl.):194.
3. Cunningham AD, Plummer CJ, McComb JM, Lord SW, Cunningham MW, Toussaint JM et al. The implantable cardioverter defibrillator: post code prescribing in the United Kingdom 1998-2002. Heart 2005;91:1280-1283
4. Seidl K, Senges J. Worldwide utilization of implantable cardioverter/defibrillators now and in the future. Card Electrophysiol Rev 2003;7:5-13.
5. Proclemer A, Ghidina M, Cicuttini G, Gregori D, Fioretti PM. The Italian Implan-table Cardioverter-Defibrillator Registry. A survey of the national activity during the years 2001-2003. Ital Heart J 2005;6:272-280
6. Swedish ICD Register. Annual Statistical Report 2004. 2004. www. pacemakerregistret.se/icdpmr/annualReport/2004/annualReport-2004-ICD.pdf.
7. National Institute for Clinical Excellence. Technology Appraisal Guidance No.11. Guidance on the use of implantable cardioverter defibrillators for arrhythmias. National Institute for Clinical Excellence. 2000. http://wwwfinice.org.uk/pdf/ Nice+DEFIBRILATOR++guidance.pdf.
8. Cunningham A, Rickards A, Cunningham M. National Pacemaker and ICD Database Annual Report. 2002. www.ic.nhs.uk/webfiles/services/NCASP/ audits%20and% 20reports/NationalPacemakerDatabase-AnnualReport-2002.pdf.
9. Cowie M. Clinical background: heart failure and implementation of the NICE/ NCC-CC guideline. In: Pearson M, Cowie M (eds). Managing Chronic Heart Failure: Learning from Best Practice. London: Royal College of Physicians; 2005.
10. Seidl K, Senges J. Geographic differences in implantable cardioverter defibrillator usage. J Cardiovasc Electrophysiol 2002;13:S100-5.
11. Ovsyshcher IE, Furman S. Determinants of geographic variation in pacemakers and implantable cardioverter defibrillators implantation rates. PACE 2003;26: 474-478
12. Lang CC. Regional variation in ICD implantation rates: the shocking truth. Heart 2005;91:1251-1253
13. Camm A, Nisam S. The utilization of the implantable cardioverter defibrillator-a European enigma. Eur Heart J 2000;21:1998-2004.
14. Boon N, Norell M, Hall J, Jennings K, Penny L, Wilson C et al. National variations in the provision of cardiac services in the United Kingdom: second report of the British Cardiac Society Working Group, 2005. Heart 2006;92
15. Hernandez AF, Fonarow GC, Liang L, Al-Khatib SM, Curtis LH, LaBresh KA et al. Sex and racial differences in the use of implantable cardioverter- defibrillators among patients hospitalized with heart failure. JAMA 2007;298:1525-1532
16. Plummer C, Irving R, McComb J. Implications of national guidance for implantable cardioverter defibrillation implantation in the United Kingdom. PACE 2003;26: 479-482
17. Plummer CJ, McComb JM. An audit of the implications of implementing NICE guidance on the use of implantable cardioverter defibrillators. Heart 2003;89:787-788
18. Plummer CJ, Irving RJ, McComb JM. The incidence of implantable cardioverter defibrillator indications in patients admitted to all coronary care units in a single district. Europace 2005;7:266-272
19. National Institute for Health and Clinical Excellence. Technology Appraisal 95. Implantable cardioverter defibrillators for arrhythmias: review of technology appraisal 11 . 2006. http://wwwfinice.org.uk/nicemedia/pdf/ TA095guidance.pdf.
20. Gregoratos G, Abrams J, Epstein AE, Freedman RA, Hayes DL, Hlatky MA et al. ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices-summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE committee to update the 1998 pacemaker guidelines). J Am Coll Cardiol 2002;40:1703-1719
21. Moss AJ, Wojciech Z, Hall WJ, Klein H, Wilber DJ, Canom DS et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002;346:877-883
22. Tod AM, Read C, Lacey A, Abbott J. Barriers to uptake of services for coronary heart disease: qualitative study. BMJ 2001;323:1-6.
23. Richards H, Reid M, Watt G. Socioeconomic variations in responses to chest pain: qualitative study. BMJ 2002;324:1308-1312
24. Pears E, Hannaford PC, Taylor MW. Gender, age and deprivation differences in the primary care management of hypertension in Scotland: a cross-sectional database study. Fam Pract 2003;20:22-31.
25. Packham C, Robinson J, Morris J, Richards C, Marks P, Gray D. Statin prescription in Nottingham general practices: a cross sectional study. J Public Health Med 1999; 21 :60-64
26. Majeed A, Moser K, Maxwell R. Age, sex and practice variations in the use of statins in general practice in England and Wales. J Public Health Med 2000;22: 275-279
27. Ward PR, Noyce PR, St Leger AS. Are GP practice prescribing rates for coronary heart disease drugs equitable? A cross sectional analysis in four primary care trusts in England. J Epidemiol Community Health 2004;58:89-96.
28. Gardner K, Chapple A. Barriers to referral in patients with angina: qualitative study. BMJ 1999;319:418-421
29. Pell J, Pell A, Morrison C, Blatchford O, Dargie H. Retrospective study of influence of deprivation on uptake of cardiac rehabilitation. BMJ 1996;313:267-268
30. Melville MR, Packham C, Brown N, Weston C, Gray D. Cardiac rehabilitation: socially deprived patients are less likely to attend but patients ineligible for thrombolysis are less likely to be invited. Heart 1999;82:373-377
31. MacLeod M, Finlayson A, Pell J, Findlay I. Geographic, demographic, and socioeconomic variations in the investigation and management of coronary heart disease in Scotland. Heart 1999;81:252-256
32. Pell JP, Pell ACH, Norrie J, Ford I. Effect of socioeconomic deprivation on waiting time for cardiac surgery: retrospective cohort study. BMJ 2000;320:15-19
33. Hippisley Cox J, Pringle M. Inequalities in access to coronary angiography and revascularisation: the association of deprivation and location of primary care services. Br J Gen Pract 2000;50:449-454
34. Black N, Langham S, Petticrew M. Coronary revascularisation: why do rates vary geographically in the UK? J Epidemiol Community Health 1995;49
35. Payne N, Saul C. Variations in use of cardiology services in a health authority: comparison of coronary artery revascularisation rates with prevalence of angina and coronary mortality. BMJ 1997;314:257.
36. Morris RW, Whincup PH, Papacosta O, Walker M, Thomson A. Inequalities in coronary revascularisation during the 1990s: evidence from the British regional heart study. Heart 2005;91:635-640
37. Scott PA, Gorman S, Andrews NP, Roberts PR, Kalra PR. Estimation of the requirement for implantable cardioverter defibrillators for the primary prevention of sudden cardiac death post-myocardial infarction based on UK national guidelines (2006). Europace 2008;10:453-457
38. Proclemer A, Ghidina M, Cicuttini G, Gregori D, Fioretti PM. Impact of the main implantable cardioverter-defibrillator trials for primary and secondary prevetion in Italy: a survey of the national activity during years 2001-2004. PACE 2006; 29 :S20-8.
39. Greenberg SM, Epstein AE, Deering T, Goldman DS, Ghidina M, Neason C et al. A comparison of ICD implantations in the United States versus Italy. PACE 2007; 30 :S143-6.
40. Lyon RM, Cobbe SM, Bradley JM, Grubb NR. Surviving out of hospital cardiac at home: a postcode lottery? Emerg Med J 2004;21:619-624